Mednet Logo
HomePulmonology
Pulmonology

Pulmonology

Physician discussions on respiratory conditions, critical care, interstitial lung disease, and pulmonary procedures.

Recent Discussions

In what clinical scenarios do you utilize post-cardiac arrest targeted temperature management (TTM)?

1 Answers

Mednet Member
Mednet Member
Neurology · Cook County Health

There still is a role for TTM in post-cardiac arrest patients. The Targeted Temperature Management After Cardiac Arrest: A Systematic Review was a systematic review of six randomized clinical trials with a total of 3870 participants that were examined. Of these, 2,767 participants were treated with ...

What is your approach to management of pulmonary fibrosis in patients with a history of microscopic polyangiitis who do not have other active organ involvement?

2
1 Answers

Mednet Member
Mednet Member
Rheumatology · Massachusetts General Hospital

ILD is an important organ manifestation in AAV, typically seen in patients with MPO-ANCA where ~20% of patients have ILD which often precedes the diagnosis of AAV. The most common radiographic pattern is UIP. ILD has been associated with a higher risk of mortality in AAV in multiple series including...

How do you approach management of osteoporosis in patients post lung transplant?

1 Answers

Mednet Member
Mednet Member
Rheumatology · U of AZ Phoenix Dept of Orthopaedics

Osteoporosis in patients with lung transplants is essentially glucocorticoid-induced osteoporosis. Most patients with severe lung disease have a long history of glucocorticoid exposure. Post-transplant, these patients are often on long-term glucocorticoids. The primary pathophysiology of chronic glu...

What is your approach to treatment in a patient with radiographic UIP but pathologic evidence of both fibrotic NSIP and UIP?

1 Answers

Mednet Member
Mednet Member
Pulmonology · University of Utah Health

Depends on the underlying etiology and progression. I will most likely use antifibrotics, particularly for IPF or progressive fibrosis, but include immune suppression for autoimmune-related ILD.

Should methotrexate be categorically avoided in RA patients with COPD or RA-ILD?

2
1 Answers

Mednet Member
Mednet Member
Rheumatology · UConn Health

Thanks for raising a very important question. It is something that every practicing Rheumatologist comes across several times during their career.The traditional teaching has always been to avoid using Methotrexate in patients with underlying pulmonary conditions due to the associated risk of Hypers...

Should MTX be avoided in RA patients with asymptomatic lung nodules?

1 Answers

Mednet Member
Mednet Member
Rheumatology · UConn Health

It is well established that in some RA patients, methotrexate does cause accelerated nodulosis predominantly in the hands which improves after stopping the medication. That does not mean having pulmonary nodules is a contraindication to use methotrexate. I recommend doing frequent chest x-rays for m...

How do you treat multisystem sarcoidosis refractory to methotrexate, humira, and remicade?

1
2 Answers

Mednet Member
Mednet Member
Rheumatology · Hospital for Special Surgery/Weill Cornell Medicine

There are many layers to this question because there are many possible explanations for treatment failure. The first issue to consider is whether the specific features of sarcoidosis being treated are best addressed through an immunosuppressive approach. Some manifestations of sarcoidosis may be ind...

Would you consider prophylactic antifungal treatment prior to immunosuppressive therapies in a patient with previously treated pulmonary coccidiomycosis and residual parenchymal changes?

1
1 Answers

Mednet Member
Mednet Member
Pulmonology · Emory University Afflilated Hospitals & Clinics

If the pulmonary coccidiomycosis was treated in the past, I would not necessarily prescribe prophylaxis, but that also depends on the meaning of "residual parenchymal changes.” If you’re referring to post-inflammatory fibrotic changes, then prophylaxis likely is unnecessary. If you’re referring to c...

When do you consider the use of steroids in the management of acute exacerbations in patients with cystic fibrosis?

1
3 Answers

Mednet Member
Mednet Member
Pulmonology · University of Arkansas for Medical Sciences

Steroids have been shown to improve FEV1 and decrease hospitalizations when used as a maintenance treatment regimen in Cystic fibrosis patients. But due to the long-term adverse effects, steroids are recommended for daily use (Mogayzel et al., PMID 23540878).Small Pilot projects showed no statistica...

Do you consider bronchoscopic lung volume reduction in patients with homogenous emphysema?

1
1 Answers

Mednet Member
Mednet Member
Pulmonology · Northwestern University Feinberg School of Medicine

The short answer to whether I consider bronchoscopic lung volume reduction (BLVR) in homogenous emphysema is yes. However, there is certainly some nuance.BLVR is gaining traction as a safer modality for lung volume reduction than a surgical intervention. Rather than undergo a partial lung resection,...